Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.680
-0.020 (-1.18%)
At close: Dec 5, 2025, 4:00 PM EST
1.710
+0.030 (1.79%)
After-hours: Dec 5, 2025, 7:12 PM EST
Bionano Genomics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bionano Genomics stock have an average target of 6.33, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 276.79% from the current stock price of 1.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bionano Genomics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $7 | Strong Buy | Maintains | $11 → $7 | +316.67% | Nov 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +554.76% | Aug 18, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +376.19% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +495.24% | Apr 9, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $1 → $4 | Hold | Maintains | $1 → $4 | +138.10% | Apr 2, 2025 |
Financial Forecast
Revenue This Year
28.72M
from 30.78M
Decreased by -6.67%
Revenue Next Year
35.78M
from 28.72M
Increased by 24.56%
EPS This Year
-6.44
from -88.13
EPS Next Year
-3.64
from -6.44
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 30.2M | 42.7M | ||||
| Avg | 28.7M | 35.8M | ||||
| Low | 27.0M | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.0% | 48.5% | ||||
| Avg | -6.7% | 24.6% | ||||
| Low | -12.4% | 2.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.20 | -2.61 | ||||
| Avg | -6.44 | -3.64 | ||||
| Low | -7.57 | -4.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.